Price
Financials
Standalone, Rs crore| Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 27 | 23 | 8 | 23 | 8 | 8 | 1 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 14 | 13 | 8 | 15 | 10 | 6 | 3 | 1 | 2 | 1 | 1 | 14 |
| Operating Profit | 13 | 10 | 0 | 8 | -2 | 2 | -2 | -1 | -2 | -1 | -1 | -14 |
| OPM % | 48% | 45% | 2.8% | 34% | -22% | 22% | -349% | -1,117% | -2,244% | -1,444% | -4,350% | -69,550% |
| Other Income | 0 | 0 | -856 | 1 | -350 | 0 | 2 | 0 | 0 | 0 | 0 | -142 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 10 | 8 | -856 | 9 | -352 | 1 | -1 | -2 | -2 | -1 | -1 | -155 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 10 | 8 | -856 | 9 | -352 | 1 | -1 | -2 | -2 | -1 | -1 | -155 |
| EPS in Rs | 0.34 | 0.28 | -28.48 | 0.29 | -11.72 | 0.05 | -0.02 | -0.06 | -0.07 | -0.04 | -0.03 | -5.17 |
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 603 | 670 | 699 | 263 | 146 | 77 | 50 | 63 | 105 | 63 | 8 | 0 |
| Expenses | 362 | 390 | 423 | 148 | 93 | 53 | 35 | 43 | 63 | 46 | 12 | 18 |
| Operating Profit | 242 | 279 | 276 | 115 | 53 | 23 | 15 | 20 | 42 | 17 | -4 | -17 |
| OPM % | 40% | 42% | 39% | 44% | 36% | 31% | 30% | 32% | 40% | 27% | -45% | -6,924% |
| Other Income | 36 | 1 | -2 | -2 | -187 | 0 | -362 | 0 | 3 | -1,204 | 2 | -141 |
| Interest | 25 | 37 | 22 | 54 | 58 | 32 | 8 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 6 | 6 | 7 | 8 | 10 | 10 | 9 | 9 | 9 | 3 | 1 | 0 |
| Profit before tax | 247 | 238 | 245 | 52 | -201 | -18 | -364 | 10 | 35 | -1,192 | -3 | -159 |
| Tax % | 1% | 1% | 2% | 18% | 0% | 3% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 244 | 235 | 241 | 42 | -202 | -18 | -364 | 10 | 35 | -1,192 | -3 | -159 |
| EPS in Rs | 10.09 | 9.69 | 9.95 | 1.74 | -8.32 | -0.74 | -15.02 | 0.35 | 1.16 | -39.63 | -0.09 | -5.28 |
| Dividend Payout % | 34% | 31% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | -55% | -65% | -87% | -97% | ||
| Compounded Profit Growth | -20% | 80% | -11% | 651% | ||
| Stock Price CAGR | -17% | -11% | % | % | ||
| Return on Equity | % | % | % | % |
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 186 | 242 | 242 | 242 | 242 | 242 | 242 | 288 | 301 | 301 | 301 | 301 |
| Reserves | 876 | 971 | 1,212 | 1,254 | 1,043 | 1,025 | 650 | 836 | 876 | -262 | -264 | -423 |
| Borrowings | 724 | 657 | 814 | 881 | 887 | 710 | 714 | 549 | 530 | 489 | 478 | 482 |
| Other Liabilities | 257 | 135 | 207 | 146 | 253 | 282 | 96 | 102 | 118 | 131 | 106 | 68 |
| Total Liabilities | 2,044 | 2,006 | 2,475 | 2,524 | 2,424 | 2,258 | 1,702 | 1,774 | 1,824 | 659 | 620 | 428 |
| Fixed Assets | 79 | 74 | 121 | 113 | 95 | 85 | 78 | 69 | 60 | 12 | 11 | 11 |
| CWIP | 1 | 1 | 1 | 1 | 0 | 102 | 102 | 157 | 158 | 0 | 0 | 0 |
| Investments | 1,114 | 382 | 382 | 382 | 382 | 382 | 382 | 437 | 447 | 202 | 202 | 20 |
| Other Assets | 849 | 1,549 | 1,971 | 2,028 | 1,948 | 1,689 | 1,141 | 1,112 | 1,159 | 445 | 407 | 397 |
| Total Assets | 2,044 | 2,006 | 2,475 | 2,524 | 2,424 | 2,258 | 1,702 | 1,774 | 1,824 | 659 | 620 | 428 |
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 118 | -30 | -93 | -16 | 56 | 335 | 57 | 47 | 42 | 21 | -5 | -3 |
| Cash from Investing Activity | -572 | 146 | -19 | -0 | 0 | -49 | -56 | -1 | -11 | 19 | 2 | -2 |
| Cash from Financing Activity | 461 | -188 | 69 | 16 | -56 | -285 | -4 | -46 | -30 | -41 | 2 | 5 |
| Net Cash Flow | 7 | -72 | -43 | 0 | -1 | 1 | -2 | 0 | 0 | -1 | 0 | 0 |
| Free Cash Flow | 113 | -30 | -147 | -16 | 56 | 333 | 56 | 46 | 41 | 21 | -3 | -3 |
| CFO/OP | 50% | -9% | -32% | -5% | 106% | 1,427% | 382% | 231% | 101% | 127% | 124% | 19% |
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 138 | 140 | 305 | 854 | 1,613 | 4 | 39 | 69 | 81 | 139 | 179 | 0 |
| Inventory Days | 265 | 266 | 336 | 1,341 | 1,943 | 3,660 | 2,459 | 394 | 237 | 475 | 1,149 | 470 |
| Days Payable | 6 | 12 | 52 | 114 | 670 | 1,827 | 173 | 292 | 289 | 792 | 4,188 | 775 |
| Cash Conversion Cycle | 397 | 395 | 589 | 2,082 | 2,887 | 1,837 | 2,324 | 171 | 29 | -179 | -2,860 | -305 |
| Working Capital Days | -88 | 307 | 495 | 1,396 | 2,023 | -1,806 | -4,111 | -2,519 | -1,474 | -2,753 | -21,186 | -671,060 |
| ROCE % | 19% | 15% | 13% | 5% | 2% | 1% | 0% | 1% | 2% | 1% | -1% | 6% |
| Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 21.53% | 21.53% | 21.56% | 20.95% | 19.30% | 19.48% | 19.48% | 19.48% | 19.48% | 19.48% | 18.52% | 18.52% |
| FIIs | 0.17% | 0.48% | 0.45% | 0.59% | 0.74% | 0.73% | 0.69% | 0.83% | 0.91% | 0.92% | 0.94% | 0.96% |
| DIIs | 1.57% | 1.56% | 1.30% | 1.28% | 0.80% | 0.81% | 0.61% | 0.82% | 0.60% | 0.61% | 0.02% | 0.02% |
| Public | 76.73% | 76.43% | 76.69% | 77.18% | 79.15% | 78.98% | 79.22% | 78.87% | 79.01% | 79.00% | 80.52% | 80.50% |
| No. of Shareholders | 90,309 | 88,361 | 87,366 | 86,786 | 85,890 | 84,869 | 84,699 | 83,805 | 83,095 | 94,119 | 95,828 | 96,217 |
Fundamentals
Market Cap₹ 54.1 Cr.
Current Price₹ 1.80
Stock P/E2.18
Book Value₹ -4.08
ROCE5.68 %
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-97%
Compounded Profit Growth (TTM)651%
Standalone figures.
Valuation
Market capRs 54 Cr
Enterprise valueRs 535 Cr
Price to book-0.44x
Price to sales245.95x
EV / sales2433.73x
Earnings yield-294.92%
P/B, 3-year average1.27x
P/E, 5-year average14.85x
P/B, 5-year average0.56x
Profitability
Operating margin (excl. other income)-6924.00%
Operating margin (incl. other income)-63520.00%
EBITDA margin-72536.36%
Pre-tax margin-72536.36%
Net profit margin-72536.36%
Net margin, latest quarter-777150.00%
ROE368.27%
ROCE-36.38%
ROA-30.32%
ROE, 3-year average54.98%
ROCE, 3-year average-47.83%
ROA, 3-year average-42.24%
ROE, 5-year average33.80%
ROCE, 5-year average-28.13%
ROA, 5-year average-24.84%
ROIC (approx.)-44.48%
Other income / net worth115.48%
Growth
Sales growth (latest year)-97.02%
Sales CAGR, 3 years-86.64%
Sales CAGR, 5 years-65.40%
Sales growth QoQ0.00%
Sales growth YoY (latest quarter)-83.33%
Per share
EPS (TTM)Rs -5.31
EPS (latest quarter)Rs -5.17
EPS, 3-year averageRs -39.63
EPS, 5-year averageRs -12.71
Book value per shareRs -4.08
Sales per shareRs 0.01
Cash flow per shareRs -0.11
Free cash flow per shareRs -0.10
Efficiency
Asset turnover0.00x
Fixed asset turnover0.02x
Inventory turnover0.78x
Inventory days470 days
Creditor days775 days
Cash conversion cycle-305 days
Working capital days-671060 days
Leverage
Total debtRs 482 Cr
Cash and bankRs 0 Cr
Net debtRs 481 Cr
Debt to equity-3.93x
Owners' fund to total sources-28.65%
Debt to assets112.65%
Cash flow
Cash from Operating Activity (latest year)Rs -3 Cr
Cash from Investing Activity (latest year)Rs -2 Cr
Cash from Financing Activity (latest year)Rs 5 Cr
Free cash flow (latest year)Rs -3 Cr
FCFE (approx.: FCF + change in debt)Rs 1 Cr
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Sales (latest quarter)Rs 0 Cr
Operating profit excl. other income (latest year)Rs -17 Cr
Operating profit (latest quarter)Rs -14 Cr
Other income (TTM)Rs -141 Cr
EBITDA (TTM)Rs -160 Cr
PBDT (TTM)Rs -160 Cr
Profit before tax (TTM)Rs -160 Cr
Net profit (TTM)Rs -160 Cr
Net profit (latest year)Rs -159 Cr
Net profit (latest quarter)Rs -155 Cr
Cost of goods sold (latest year)Rs 6 Cr
Total expenditure (latest year)Rs 18 Cr
Total income (latest year)Rs -141 Cr
Share capitalRs 301 Cr
ReservesRs -423 Cr
Shareholders' fundsRs -123 Cr
Total assetsRs 428 Cr
Net blockRs 11 Cr
InvestmentsRs 20 Cr
InventoryRs 8 Cr
Other liabilitiesRs 68 Cr
Shares outstanding (crore)30.06
Ownership
Promoter holding18.52% (-0.96 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 1.49 is at the 65th percentile (median 0.30).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | OPTOCIRCUI | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -18.2% | -2.8% | -15.4 pts |
| 1 month | -26.5% | -6.8% | -19.7 pts |
| 3 months | -50.7% | -7.6% | -43.1 pts |
| 6 months | -62.9% | +0.4% | -63.3 pts |
| 1 year | -70.0% | -9.9% | -60.1 pts |
| 2 years | -36.8% | -13.6% | -23.3 pts |
| 3 years | -74.8% | +14.2% | -89.0 pts |
| 5 years | -81.3% | +27.9% | -109.2 pts |
Red flags
F-score 2 of 8| serious | Negative equity Shareholders' equity is negative |
| look | Inventory outrunning sales Inventory grew -44% vs sales -97% in 2022 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2022Sales ₹0 Cr.
Net loss ₹155 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Poly Medicure Ltd | 16,671 | 52.1 | 12.5 % |
| Molbio Diagnostics Ltd | 14,470 | 66.6 | 18.0 % |
| Fischer Medical Ventures Ltd | 2,355 | 96.2 | 11.4 % |
| Tarsons Products Ltd | 1,754 | 148 | 4.59 % |
| Q-Line Biotech Ltd | 1,569 | 27.8 | 22.5 % |
| Laxmi Dental Ltd | 1,058 | 30.4 | 15.0 % |
| Hemant Surgical Industries Ltd | 869 | 51.3 | 18.9 % |
| Vasa Denticity Ltd | 754 | 62.3 | 7.54 % |
| OSEL Devices Ltd | 691 | 23.6 | 24.4 % |
| Prevest Denpro Ltd | 462 | 20.5 | 24.9 % |
| QMS Medical Allied Services Ltd | 419 | 39.0 | 12.9 % |
| Nureca Ltd | 349 | 80.4 | 3.30 % |
| Aprameya Engineering Ltd | 200 | 39.7 | 12.6 % |
| Avience Biomedicals Ltd | 198 | 22.7 | 27.0 % |
| Earkart Limited | 179 | 36.3 | 17.5 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2020-12-24 | Annual General Meeting | |
| 2019-09-25 | Annual General Meeting | |
| 2018-09-21 | Annual General Meeting (Date Revised) | |
| 2017-08-29 | Annual General Meeting | |
| 2016-09-01 | Annual General Meeting | |
| 2015-12-23 | Annual General Meeting | |
| 2014-09-24 | Annual General Meeting | |
| 2013-09-24 | Annual General Meeting | |
| 2012-09-21 | Annual General Meeting/Dividend Rs 3 Per Share | |
| 2012-03-29 | Bonus 3:10 | 0.7692 |
| 2011-09-21 | Dividend-Rs.4.50 Per Share | |
| 2010-09-21 | Annual General Meeting And Dividend Rs.4/- Per Share | |
| 2009-09-18 | Dividend-Rs.4/- Per Share | |
| 2008-11-03 | Bonus 7:10 | 0.5882 |
| 2008-09-24 | Agm/Dividend - 50% | |
| 2007-10-25 | Bonus 1:2 | 0.6667 |
| 2007-09-18 | Agm/Dividend--50% | |
| 2006-10-30 | Bonus 1:1 | 0.5000 |
| 2006-09-20 | Agm/Dividend-40% |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Opto Circuits (India) Ltd?
Opto Circuits (India) Ltd (OPTOCIRCUI) has a market capitalisation of Rs 54.1 Cr. at the 2022-05-23 close.
What is the P/E ratio of Opto Circuits (India) Ltd?
Opto Circuits (India) Ltd trades at a P/E of 2.18 on trailing twelve-month profit, at the 2022-05-23 close.
What were Opto Circuits (India) Ltd's latest quarterly results?
In the Mar 2022 quarter, Opto Circuits (India) Ltd sales was Rs 0 Cr with a net loss of Rs 155 Cr.